Rainbow Children's Medicare Limited Reports Q1 FY27 Results: Consolidated Net Profit Rises 16.2% YoY to ₹62.54 Crore

Rainbow Children's Medicare Limited (RCML), a leading multi-specialty pediatric, fetal, and maternal healthcare chain in India, has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27). The company delivered strong top-line growth driven by higher operational revenues across its network.

Consolidated Financial Highlights

All figures in ₹ Million unless explicitly stated otherwise.

For Q1 FY27, Rainbow Children's Medicare reported a consolidated Net Profit After Tax (PAT) of ₹625.40 million (₹62.54 crore), representing a 16.23% year-on-year increase compared to ₹538.05 million (₹53.81 crore) in Q1 FY26. Profit attributable to owners of the company stood at ₹605.72 million.

Total consolidated income for the quarter reached ₹4,826.98 million (₹482.70 crore), marking a 29.43% year-on-year expansion compared to ₹3,729.45 million in Q1 FY26 and up 3.81% sequentially from ₹4,649.68 million in Q4 FY26.

Revenue from Operations: Grew 33.17% year-on-year to ₹4,699.85 million (₹469.99 crore) in Q1 FY27, up from ₹3,529.29 million in Q1 FY26 and ₹4,599.01 million in Q4 FY26.

Other Income: Stood at ₹127.10 million for Q1 FY27, compared to ₹200.16 million in Q1 FY26 and ₹50.64 million in Q4 FY26.

Total Expenses: Rose to ₹3,987.42 million in Q1 FY27 from ₹3,015.71 million in Q1 FY26. Major cost components included:

Professional Fees to Doctors: ₹1,238.19 million (vs. ₹917.58 million in Q1 FY26).

Other Expenses: ₹801.29 million (vs. ₹584.30 million in Q1 FY26).

Employee Benefits Expense: ₹668.50 million (vs. ₹516.20 million in Q1 FY26).

Cost of Materials Consumed: ₹645.42 million (vs. ₹474.98 million in Q1 FY26).

Depreciation & Amortisation: ₹421.97 million (vs. ₹341.87 million in Q1 FY26).

Finance Costs: ₹212.05 million (vs. ₹180.78 million in Q1 FY26).

Profit Before Tax (PBT): Rose 17.62% year-on-year to ₹839.53 million for Q1 FY27, compared to ₹713.74 million in Q1 FY26.

Total Tax Expense: Stood at ₹214.13 million (comprising ₹222.84 million current tax and ₹(8.71) million deferred tax credit).

Total Comprehensive Income: Stood at ₹623.61 million for Q1 FY27, compared to ₹537.90 million in Q1 FY26.

Standalone Performance Summary

All figures in ₹ Million unless explicitly stated otherwise.

On a standalone basis, RCML reported:

Revenue from Operations: Reached ₹4,105.47 million (₹410.55 crore) in Q1 FY27, registering a 22.64% year-on-year growth compared to ₹3,347.48 million in Q1 FY26.

Total Income: Stood at ₹4,233.04 million, up 19.57% year-on-year from ₹3,540.33 million in Q1 FY26.

Total Expenses: Came in at ₹3,527.63 million, compared to ₹2,852.13 million in Q1 FY26. Key costs were doctor professional fees (₹1,087.30 million), other expenses (₹725.65 million), and employee expenses (₹599.08 million).

Profit Before Tax (PBT): Stood at ₹705.41 million for Q1 FY27, compared to ₹688.20 million in Q1 FY26.

Net Profit After Tax (PAT): Reached ₹527.06 million (₹52.71 crore) for Q1 FY27, up from ₹517.20 million in Q1 FY26.

Total Comprehensive Income: Stood at ₹525.41 million for Q1 FY27.

Earnings Per Share & Capital Base

Consolidated EPS: Basic and diluted Earnings Per Share for Q1 FY27 increased to ₹5.97 per share (face value ₹10.00 each, not annualised), up from ₹5.27 per share in Q1 FY26.

Standalone EPS: Basic and diluted EPS stood at ₹5.20 per share for Q1 FY27, compared to ₹5.09 per share in Q1 FY26.

Paid-Up Equity Share Capital: Stood at ₹1,015.66 million (face value ₹10.00 each) as of June 30, 2026.

Shares of Rainbow Childrens Medicare Limited was last trading in BSE at Rs. 1516.00 as compared to the previous close of Rs. 1495.90. The total number of shares traded during the day was 11446 in over 1023 trades.

The stock hit an intraday high of Rs. 1531.00 and intraday low of 1480.00. The net turnover during the day was Rs. 17277633.00.

Source : Equity Bulls

Keywords

RainbowChildrensMedicare INE961O01016 Hospital Q1FY27 Q1FY2027 ResultUpdate